A Denial Is Not a No

Transcript

A denial is not always a no. Sometimes, it is just the first step in getting the medication covered. 

In this episode, Dr. Albert Takem explains what patients can do when insurance denies coverage for weight loss medications like Wegovy, Zepbound, Ozempic, or Mounjaro. He breaks down why GLP-1 medications are often denied, why prior authorizations matter, and how other medical conditions may create a different pathway to coverage. 

Dr. Takem also discusses manufacturer programs, oral medication options, copay cards, patient assistance programs, and why patients should be careful with compounded GLP-1 products. 

We discuss: 

•  Why insurance often denies weight loss medications 
•  Why obesity treatment is still treated differently by many insurance plans 
•  How sleep apnea, diabetes, cardiovascular disease, and fatty liver disease can affect coverage 
•  What prior authorization and peer-to-peer review mean 
•  Why a full medical workup matters before prescribing GLP-1 medications 
•  Manufacturer direct-purchase options and copay assistance 
•  Why compounded GLP-1 products may carry safety concerns 

If your medication was denied, do not assume the conversation is over. Talk with your doctor about the next step, the right diagnosis, the appeal process, and safer ways to access treatment.
 
This episode is for education only and does not replace medical advice. Always speak with your own physician about your individual health situation.

Questions for Dr. Takem and the team

💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://www.maryland-primarycare.com/